Imunon (IMNN) Shares Outstanding (2010 - 2026)

Imunon (IMNN) has 17 years of Shares Outstanding (Entity) data on file, last reported at $5.0 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 415.89% year-over-year to $5.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.0 million (up 415.89% YoY) and the FY2025 annual result came in at $2.1 million, up 176.75% from the prior year.
• Shares Outstanding (Entity) advanced to $5.0 million in Q1 2026, from $2.1 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $5.0 million in Q1 2026 to a low of $384717.0 in Q1 2022.
• A 5-year average of $1.2 million and a median of $626759.0 in 2024 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) climbed 1.61% — and 2026, when it surged 415.89%.
• Tracing IMNN's Shares Outstanding (Entity) over 5 years: stood at $495773.0 in 2022, then climbed by 26.41% to $626685.0 in 2023, then gained by 22.43% to $767249.0 in 2024, then jumped by 176.75% to $2.1 million in 2025, then soared by 136.83% to $5.0 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $5.0 million (Q1 2026), $2.1 million (Q4 2025), and $2.9 million (Q3 2025), per Business Quant data.